Cargando…
Interstitial inflammation and pulmonary fibrosis in COVID-19: The potential role of cytostatic therapy for severe lung injury
The progression of secondary pulmonary damage in SARS-COV-2 infection, associated with interstitial damage, inflammation and alveolar consolidation and eventually resulted in the development of pulmonary fibrosis (PF), remains one of the key clinical dilemmas for the treatment of patients in intensi...
Autores principales: | Filimonova, Elena V., Davydova, Lyubov A., Lysenko, Mariana A., Tsarenko, Sergey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135639/ https://www.ncbi.nlm.nih.gov/pubmed/35663110 http://dx.doi.org/10.1016/j.rmcr.2022.101676 |
Ejemplares similares
-
Correction of Anticoagulant Therapy in Patients with Severe COVID-19
Virus Infection Using a Thrombodynamics Coagulation Assay
por: Vuimo, Tatiana S., et al.
Publicado: (2022) -
Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
por: Nashatyreva, Maria S., et al.
Publicado: (2023) -
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation
por: Zheng, Meiling, et al.
Publicado: (2019) -
Progressive Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
por: Rose, Jonathan A., et al.
Publicado: (2022) -
Clinical Images: Severe interstitial lung disease in Sjögren disease — What happens in the lungs? Inflammation or fibrosis?
por: Hoffmann, Tobias, et al.
Publicado: (2022)